Pregled bibliografske jedinice broj: 63993
Paraoxonase polymorphism in cardiovascular diseases (CAD)
Paraoxonase polymorphism in cardiovascular diseases (CAD) // European Journal of Human Genetics : Programme and abstracts / Van Ommen, Gert-Jan B. (ur.).
Hampshire: Stockton Press, 1999. str. 131-132 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 63993 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Paraoxonase polymorphism in cardiovascular diseases (CAD)
Autori
Ivanišević, Ana-Maria ; Štefanović, Mario ; Topić, Elizabeta ; Nikolić, Vjeran ; Petrač, Dubravko ; Čubrilo-Turek, Mirjana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
European Journal of Human Genetics : Programme and abstracts
/ Van Ommen, Gert-Jan B. - Hampshire : Stockton Press, 1999, 131-132
Skup
31st Annual Meeting of the European Society for Human Genetics
Mjesto i datum
Ženeva, Švicarska, 29.05.1999. - 01.06.1999
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
PON1 gene; cardiovascular diseases
Sažetak
Paraoxonase (PON1) genetic polymorphism at codon 192 (glutamine to arginine substitution, genotypes A and B, respectively) has been shown to affect the risk of CVD. The aim of this study was to genotype 44 controls and 100 CVD patients with different diagnosis (coronary artery disease (CAD), myocardial infarction (MI), hypertension and carotid stenosis (CS)) by PCR-RFLP using Alw1 restriction enzyme. Study results showed that out of 44 controls 18/44 (40.9%) were A and 1/44 (2.3%) B homozygotes and 25/44 (56.8%) heterozygotes. Among 31 CAD patients 9/31 (29.0%) were A and 5/31 (16.1%) B homozygotes and 17/31 (54.8%) heterozygotes. In 27 MI patients 8/27 (29.6%) were A and 4/27 (14.8%) B homozygotes and 15/27 (55.6%) heterozygotes. Out of 16 hypertension patients 6/16 (37.5%) were A and 3/16 (18.8%) B homozygotes and 7/16 (43.8%) heterozygotes. Among 26 CS patients 15/26 (57.7%) were A and 2/26 (7.7%) B homozygotes and 9/26 (34.6%) heterozygotes. Genotypes between controls and patients differed significantly (Chi-square test ; P=0.002, 0.003, <0.001 and 0.003 ; for CAD, MI, Hypertension and CS patients, respectively). Allelic frequencies did not differ significantly between controls and patients. Our findings indicate the association between the codon 192 polymorphism of PON1 gene and cardiovascular diseases.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Projekti:
134003
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Mirjana Čubrilo-Turek
(autor)
Vjeran Nikolić-Heitzler
(autor)
Mario Štefanović
(autor)
Dubravko Petrač
(autor)
Elizabeta Topić
(autor)